Article By:
MoneyShow.com
Sunday, July 4, 2021 12:41 PM EDT
Celldex Therapeutics (CLDX) remains one of our Top Picks for 2021 with the company delivering value creating data updates so far this year. The stock has risen 53% so far this year.
In this article: CLDX